Home » Newsletters » BioWorld Science

BioWorld Science

June 22, 2001

View Archived Issues

PROGRESS trials show Aceon/diuretic combination reduces recurrent stroke by 50%

Technology applicable to dengue vaccine available for licensing

Licensing opportunity from NIH: chimeric protein with potential as antiinfective therapeutic

GSK committed to development of infectious disease treatments

Valdecoxib compares favorably to conventional NSAIDs in terms of both efficacy and safety

KS Biomedix to acquire Avicenna; obtains exclusive license to antibody products

Major beneficial effects reported for DP-b99 in focal and global cerebral ischemia

Orally active SARM exerts anabolic effects on bone and muscle in androgen-deficient rats

Phase II clinical trial of ISIS-104838 commences in patients with psoriasis

Amylin's AC-2993 reaches endpoint in type 2 diabetes trial

Recruitment begins in phase II trial of BBR-3464 for pancreatic cancer

Novel class of molecules --the SGRMs-- with potential therapeutic benefits over glucocorticoids

Genentech returns rights to respiratory compounds to Inspire

Second multicenter phase I/II trial of GVAX for NSCLC

Phase II data on Insmed's lead product discussed at ENDO 2001

Prescient NeuroPharma identifies neurotrophic factor genes

Numerous studies published recently on soon-to-be-introduced ARB olmesartan

Viragen cleared to begin clinical trials of Omniferon for MS in the U.K.

Oxford GlycoSciences and NeoGenesis enter drug discovery alliance

IntraDose plus systemic chemotherapy evaluated in H&N cancer patients

GW-471558: a new azasordarin with potent anticandidal activity

Fujisawa describes new NO production inhibitors and their uses

Italian research group discovers protease inhibitors useful for HCV

Pharmacia presents new oxazolidinone antibacterial agents

Novel compounds act as antagonists at 5-ht6 receptors and are useful for Rx of CNS disorders

Vasopressin antagonists reported by Ortho-McNeil in patent literature

NMDA antagonists with anticonvulsant activity synthesized at Merz

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...